Literature DB >> 1186493

Deep mycotic infection in the hospitalized adult: a study of 123 patients.

H D Rose, B Varkey.   

Abstract

A prospective study of patients hospitalized in a large Veterans Administration Hospital between November 1963 and November 1973 revealed 123 patients with deep mycotic infections. The incidence of these infections almost doubled during the last 5 years. Candida (55 patients) and Aspergillus (26 patients) were the major causative agents. Nine other fungal caused infection in the remaining patients. Candidemia was rare prior to the introduction of commerical percutaneously-inserted venous catheters in 1965. The incidence increased further following the introduction of parenteral hyperalimentation in 1969, and Torulopsis fungemia (5 patients) appeared for the first time. Invasive pneumonia caused by spore-forming Aspergillus decreased when patients were moved from an old, naturally-ventilated hospital to a new, mechanically-ventilated one. The air in both hospitals was sampled on one occasion for the presence of fungal spores, and spores of Aspergillus fumigatus were detected only in the old hospital. Our experience suggests that hospital-acquired Aspergillus infection of the lung might be eliminated if all incoming hospital air is filtered, properly vented, and not recirculated. Efforts to decrease hospital-acquired fungal infections include vigorous infection control procedures for intravenous therapy, judicious use of any therapy that predisposes to infection, and further evaluation of improved mechanical control of hospital ventilation.

Entities:  

Mesh:

Year:  1975        PMID: 1186493     DOI: 10.1097/00005792-197511000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  18 in total

1.  Detection of Candida antigenuria in disseminated candidiasis by immunoblotting.

Authors:  R P Ferreira; B Yu; Y Niki; D Armstrong
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.

Authors:  A Schaffner; C E Davis; T Schaffner; M Markert; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  Invasive aspergillosis in a "healthy" patient.

Authors:  K J Ascah; R H Hyland; M A Hutcheon; S J Urbanski; W Pruzanski; E L St Louis; D P Jones; E C Keystone
Journal:  Can Med Assoc J       Date:  1984-08-15       Impact factor: 8.262

5.  Biochemical examination of sera during systemic Candida infection in mice.

Authors:  D Oblack; J Schwarz; I A Holder
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

6.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis.

Authors:  R D Diamond; R Krzesicki; B Epstein; W Jao
Journal:  Am J Pathol       Date:  1978-05       Impact factor: 4.307

8.  Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.

Authors:  J Berenguer; N M Ali; M C Allende; J Lee; K Garrett; S Battaglia; S C Piscitelli; M G Rinaldi; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Fungal infections in liver transplant recipients.

Authors:  C P Wajszczuk; J S Dummer; M Ho; D H Van Thiel; T E Starzl; S Iwatsuki; B Shaw
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

10.  Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.

Authors:  J S Solomkin; A Flohr; R L Simmons
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.